Douglas Carr
Svp Finance & Operations at Century Therapeutics, Inc. (IPSC)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $29K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 15SEC | IPSCCentury Therapeutics, Inc. | Sell | 1,658502,907 held (−0%) | $1.93 | $3K | -23.8% |
| Sep 9SEC | IPSCCentury Therapeutics, Inc. | Sell | 254504,565 held (−0%) | $2.05 | $521 | -28.3% |
| Aug 5SEC | IPSCCentury Therapeutics, Inc. | Sell | 275504,819 held (−0%) | $1.98 | $544 | -25.8% |
| Jun 15SEC | IPSCCentury Therapeutics, Inc. | Sell | 1,654505,094 held (−0%) | $2.23 | $4K | -34.1% |
| Jun 9SEC | IPSCCentury Therapeutics, Inc. | Sell | 249506,748 held (−0%) | $2.11 | $525 | -30.3% |
| May 6SEC | IPSCCentury Therapeutics, Inc. | Sell | 264506,997 held (−0%) | $2.34 | $618 | -37.2% |
| Mar 16SEC | IPSCCentury Therapeutics, Inc. | Sell | 7,043507,261 held (−1%) | $2.55 | $18K | -42.4% |
| Mar 11SEC | IPSCCentury Therapeutics, Inc. | Sell | 247514,304 held (−0%) | $2.54 | $627 | -42.1% |
| Feb 5SEC | IPSCCentury Therapeutics, Inc. | Sell | 323514,551 held (−0%) | $1.82 | $588 | -19.2% |
| Dec 10SEC | IPSCCentury Therapeutics, Inc. | Sell | 257404,874 held (−0%) | $0.53 | $136 | +177.4% |
| Nov 5SEC | IPSCCentury Therapeutics, Inc. | Sell | 292405,131 held (−0%) | $0.59 | $172 | +149.2% |